INVO BioScience, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
2.00
|
|
Average Rating
|
3.00
|
|
# Strong Buys
|
0
|
|
# Buys
|
0
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.13
|
-0.21
|
-0.08
|
-61.54%
|
|
2022-06-30
|
-0.24
|
-0.23
|
0.01
|
4.17%
|
|
2022-03-31
|
-0.25
|
-0.23
|
0.02
|
8.00%
|
|
2021-12-31
|
-0.22
|
-0.01
|
0.21
|
95.45%
|
|
2021-09-30
|
-0.20
|
-0.24
|
-0.04
|
-20.00%
|
|
2021-06-30
|
-0.19
|
-0.17
|
0.02
|
10.53%
|
|
2021-03-31
|
-0.17
|
-0.25
|
-0.08
|
-47.06%
|
|
2020-12-31
|
-0.21
|
-0.60
|
-0.39
|
-185.71%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.67
|
|
2021-12-31
|
-0.67
|
|
2020-12-31
|
-1.31
|
|
2019-12-31
|
-0.64
|
|
2018-12-31
|
-0.27
|
|
2017-12-31
|
-0.16
|
|
2016-12-31
|
-0.49
|
|
2015-12-31
|
-0.86
|
|
2010-12-31
|
-0.67
|
|
2009-12-31
|
-2.99
|
|
2008-12-31
|
-1.05
|